Thursday, October 18, 2018 12:00:36 PM
PayChest Receives FundsPress Release | 03/27/2017
Paychest has received $25,000 in exchange for 25,000 Preferred B shares. Funds are being used
to make OTC current, enable FINRA to continue the Company's restructuring review, and
address other essential payables necessary to complete the restructuring. Finders fees of 4% have
been paid in the form of Preferred B Shares.
The Company expects to provide further updates shortly.
NOTE ABOUT FORWARD-LOOKING STATEMENTS
Except for any historical information contained herein, the matters discussed in this press release
contain forward-looking statements that involve risks and uncertainties, including those
described in the Company's filings with OTC Markets
http://www.otcmarkets.com/stock/PYCT/financials. ;
Certain statements contained in this release that are not historical facts constitute forward-
looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995,
and are intended to be covered by the safe harbors created by that Act. Reliance should not be
placed on forward looking statements because they involve unknown risks, uncertainties and
other factors which may cause actual results, performance or achievements to differ materially
from those expressed or implied. Forward looking statements may be identified by words such
as estimates, anticipates, projects, plans, expects, intends, believes, should and similar
expressions and by the context in which they are used. Such statements are based upon current
expectations of the Company and speak only as of the date made.
Contact: Paychest, Inc. ir@paychest.com
Investor Relations: 1-360-200-0986
Source: PayChest Inc.
Historical news releases on the Company can be found at http://www.paychest.com/news.htm.
*************************************************
I NOTICED IF CALLING INVESTOR RELATIONS AT THE PHONE# LISTED ABOVE (1-360-200-0986), it's IBM from Washington State.
Good luck to all !
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM